Incidence and Clinical Progression of Asymptomatic PICC-Related Thrombosis in Solid Cancer Patients
Asymptomatic PICC-related Thrombosis in Cancer Patients: a Prospective Cohort Study of an Ultrasound-guided Approach.
1 other identifier
observational
120
1 country
1
Brief Summary
In this prospective cohort study, the investigators evaluated the incidence of superficial vein thrombosis, deep vein thrombosis, and fibroblastic sleeve formation in solid cancer patients undergoing chemotherapy. The study aimed to shed light on the clinical progression of venous thrombosis in cancer patients with central venous catheters, with a particular focus on certain cancer types associated with a higher risk of venous thromboembolism (VTE). The investigators believe that such findings hold significant clinical relevance as a substantial portion of the study population was affected by pancreatic cancer, a cancer type known to carry a high risk of thrombotic events. This research adds valuable insights into understanding asymptomatic PICC-related thrombosis in this specific subgroup of cancer patients, which can aid in developing effective management strategies for venous access in this challenging population. The study employed an ultrasound-guided approach for follow-up at 30 and 90 days after catheter insertion, enabling us to detect and treat asymptomatic PICC-VTE in a timely manner. Identifying independent risk factors for catheter-related thrombosis, including age and cancer type, has further enhanced the clinical applicability of our findings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
July 21, 2023
CompletedFirst Posted
Study publicly available on registry
August 1, 2023
CompletedAugust 2, 2023
August 1, 2023
3 years
July 21, 2023
August 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Catheter related thrombosis
Symptomatic and asymptomatic upper extremities thrombosis
1 month and 3 months from baseline
Secondary Outcomes (1)
PICC vs PICC-PORT
1 month and 3 months from baseline
Study Arms (1)
Solid cancer patients
Patients with solid cancer who underwent the placement of a PICC or PICC-PORT for chemotherapy.
Interventions
Ultrasound diagnosi of asymptomatic and symptomatic upper extremities vein thrombosis
Eligibility Criteria
Patients with solid cancer undergoing chemotherapy
You may qualify if:
- patients with:
- a documented active malignancy;
- PICC or PORT placement for systemic chemotherapy;
You may not qualify if:
- patients with:
- a communication disorder;
- contraindications to anticoagulation therapy;
- hematopathy;
- expected survival of less than one month;
- were lost to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliera Universitaria Integrata
Verona, 37134, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mattia Cominacini, MD
Azienda Ospedaliera Universitaria Integrata Verona
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 21, 2023
First Posted
August 1, 2023
Study Start
January 1, 2020
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
August 2, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share